Janus Detroit Street Trust Small.Mid Cap Growth Alpha

Medpace Holdings CEO Announces Sale of Common Stock

Argan Reports Third Quarter Earnings Per Share of $2.17

Trump administration provides cash subsidies to nuclear projects

Argan Expected to Release Q3 2023 Earnings After December 4 Close

Jabil's Executive Chairman Mark T. Mondello Selling Common Stock

Jabil to Release Q1 2026 Financial Results

Pinkerton Wealth LLC Buys Jabil Shares; Insiders Cut Their Positions

Argan, Inc. sees gap-down opening despite strong earnings

BWX Technologies Consortium Secures Owner Engineer Services Contract for Bulgarian Nuclear Plant Expansion

Medpace CEO Sells Company Shares

TopBuild Corp executive sells company common stock

Findlay Park Partners LLP reduces holdings in TopBuild Corp.

Ameritas Investment Partners Inc. Sells Shares of Jabil Inc.

Argan to Release FY2026 Q3 Earnings on December 4, 2025, After-Market EST; Forecast Revenue USD 264.93 M, EPS USD 1.716

Medpace Holdings EVP Susan E. Burwig Reports Sale of Common Stock

Medpace Holdings Hits New 52-Week High and Reports Strong Quarterly Earnings

Installed Building Products Inc. Repurchased 150,000 Shares

Medpace CEO August J. Troendle Disposes of Common Stock

Medpace VP Files Form 144 to Prepare for Sale of 20,000 Restricted Shares

AXQ Capital LP Increases Jabil Shares, Jabil Reports Strong Earnings and Announces Dividends

SEVEN HILLS RLTY TR COM USD0.001 (S/R 04/12/2025)

SMX Security Matters

Polyrizon

Picard Medical

Synchronoss Tech

PharmaCyte Biotech

Q/C Tech

Rich Sparkle

Hoyne Bancorp

Tradr 2X Long ASTS Daily ETF

JBL has launched the PartyBox 720, featuring 800W JBL Pro Sound, AI Sound Boost, and a dynamic light show. It offers 15 hours of playtime with dual replaceable batteries and is splashproof. The speaker is designed for easy mobility with sturdy wheels and an ergonomic handle. Available mid-December for RM4,999, it can be purchased online. JBL continues to innovate in audio technology, enhancing music experiences globally.

Acceswire

Jabil

More Than Just Sound. Get The Crowd Moving with JBL PartyBox 720

HALO

Health-care stocks fell sharply as traders shifted to rate-sensitive sectors. Halozyme secured a preliminary injunction against Merck & Co. in a patent dispute over Keytruda in Germany. The Trump administration's biomedical innovation goals face challenges within the FDA, amid infighting and staff turnover influenced by Robert F. Kennedy Jr.'s policy changes.

marketscreener

Merck

Halozyme Therap

Health Care Down Sharply on Rotation to Rate-Sensitive Sectors -- Health Care Roundup

Jabil Inc. (JBL) shares rose 2.18% to $218.72, marking the third consecutive day of gains, despite a mixed trading session. The stock is 7.77% below its 52-week high of $237.14. Compared to competitors, Jabil's performance was mixed, with Benchmark Electronics up 0.60%, Flex Ltd. up 4.12%, and Sanmina Corp. up 2.10%. Trading volume was below the 50-day average.

Dow Jones

Jabil Inc. Stock Outperforms Competitors On Strong Trading Day

MEDP

August J. Troendle, CEO and Director of Medpace Holdings Inc., reported the sale of common shares. This information was published via EDGAR by the U.S. Securities and Exchange Commission. The news is generated by Public Technologies using AI and is for informational purposes only.

Reuters

Medpace

Medpace CEO August J. Troendle Reports Sale of Common Shares

LB filings

Argan

Argan | 10-Q: FY2026 Q3 Revenue Misses Estimate at USD 251.15 M

Argan's fiscal Q3 revenue declined by 2.3% year-over-year, missing analyst estimates, but net income rose to $30.7 million. The company reported a record backlog of $3.0 billion, driven by new gas-fired projects. Despite the revenue decline, gross profit margins improved. Analysts maintain a 'buy' rating, with a median 12-month price target of $370.00, 5.4% above the recent closing price. The stock trades at 39 times the next 12-month earnings.

Industrial contractor Argan's Q3 revenue misses estimates

Argan Inc. reported Q3 revenues of USD 251.2 million and a project backlog of USD 3.0 billion, more than double the previous level. Nine-month revenues were USD 682.6 million, a 6.4% increase. Q3 gross profit was USD 46.9 million, and net income was USD 30.7 million. EBITDA for Q3 was USD 40.3 million. The company has no debt and cash equivalents totaling USD 726.8 million as of October 31, 2025.

Argan Inc. Q3 project backlog rises to USD 3.0 billion, more than double previous level

Dec 4 (Reuters) - Halozyme Therapeutics Inc:HALOZYME WINS PRELIMINARY INJUNCTION AGAINST MERCK’S KEYTRUDA SC IN GERMANYHALOZYME THERAPEUTICS: AS CONSEQUENCE OF INJUNCTION MERCK’S LAUNCH ACTIVITIES FOR KEYTRUDA SC IN GERMANY WITHIN SCOPE OF ORDER MUST BE HALTEDHALOZYME THERAPEUTICS: OUTCOME OF THE INFRINGEMENT LAWSUIT AGAINST MERCK WILL NOT IMPACT ENHANZEHALOZYME THERAPEUTICS INC - IV VERSION OF KEYTRUDA REMAINS AVAILABLE TO PATIENTS Source text: Further company coverage:

Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC In Germany

BWXT

BWX Technologies (BWXT) has secured a decade-long role for Bulgaria's Kozloduy expansion and advanced TRISO fuel deliveries for the U.S. Army's Project Pele. Despite a strong share price performance, BWXT is seen as 20.6% undervalued with a fair value of $220. The stock trades at a high earnings multiple, suggesting limited margin for error. Investors should consider risks like US defense funding changes. The analysis highlights rewards and warning signs for BWXT's investment potential.

Simplywall

BWX Tech

BWX Technologies (BWXT): Assessing Valuation After Kozloduy Expansion Win and Project Pele TRISO Fuel Progress

Argan SA has completed a project to replace gas boilers with heat pumps in Decathlon warehouses, reducing CO₂ emissions by 700 tons annually. This is part of Argan's strategy to cut emissions from 24,000 tons in 2022 to 12,000 tons by 2030, without disrupting logistics operations.

Argan SA Replaces Gas Boilers With Heat Pumps at Decathlon Warehouses to Cut Carbon Emissions

Installed Building Products reported record Q3 net revenue and higher net income, announced a 150,000-share repurchase, and received a BB+ long-term issuer rating from Fitch. These developments highlight strong cash flow and balance sheet strength, with management actively returning capital to shareholders. The BB+ rating emphasizes conservative leverage and liquidity, crucial if earnings growth normalizes. Despite a stronger credit profile, IBP remains exposed to construction cycles. The narrative projects $3.0 billion revenue and $250.9 million earnings by 2028, implying a slight revenue decline and earnings increase.

Installed Building Products

How Record Q3 Results, Buybacks, and a New BB+ Rating At Installed Building Products (IBP) Has Changed Its Investment Story

Argan (AGX) will announce its FQ3 earnings on December 4th, post-market. The expected EPS is $2.10, and revenue is estimated at $264.93M. Historically, AGX has surpassed EPS estimates 75% of the time and revenue estimates 88% of the time over the past two years.

Argan FQ3 2026 earnings preview

Medpace Holdings Insider Sold Shares Worth $17,114,847, According to a Recent SEC Filing

Medpace Holdings Insider Sold Shares Worth $17,114,847, According to a Recent SEC Filing

Medpace Holdings Inc.'s CEO, August J. Troendle, reported the disposal of common shares. This information was published via the U.S. SEC's EDGAR system. The news is generated by Public Technologies using AI and is for informational purposes only.

Medpace CEO August J. Troendle Reports Disposal of Common Shares